Skip to main content
Back
IUSDF logo

AS ONE Corporation

Data quality: 100%
Oversold
IUSDF
OTC Healthcare Medical - Distribution
$14.00
$0.00 (0.00%)
Mkt Cap: 997.73M
Day Range
$14.00 $14.00
52-Week Range
$14.00 $14.00
Volume
100
50D / 200D Avg
$14.00 / $14.00
Prev Close
$14.00

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E 0.1 0.4
P/B 0.0 2.9
ROE % 12.5 3.7
Net Margin % 7.9 3.8
Rev Growth 5Y % 6.2 10.0
D/E 0.1 0.2

Key Takeaways

Revenue grew 6.19% annually over 5 years — modest growth
ROE of 12.53% — decent returns on equity
Debt/Equity of 0.11 — conservative balance sheet
Generating 7.52B in free cash flow
P/E of 0.12 — trading at a low valuation
Cash machine — converts 91.41% of earnings into free cash flow

Growth

Revenue Growth (5Y)
6.19%
Revenue (1Y)8.60%
Earnings (1Y)9.72%
FCF Growth (3Y)13.72%

Quality

Return on Equity
12.53%
ROIC11.77%
Net Margin7.93%
Op. Margin11.17%

Safety

Debt / Equity
0.11
Current Ratio2.64
Interest Coverage1449.13

Valuation

P/E Ratio
0.12
P/B Ratio0.01
EV/EBITDA-1.24
Dividend Yield0.02%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 8.60% Revenue Growth (3Y) 6.53%
Earnings Growth (1Y) 9.72% Earnings Growth (3Y) 0.71%
Revenue Growth (5Y) 6.19% Earnings Growth (5Y) 8.27%
Profitability
Revenue (TTM) 103.75B Net Income (TTM) 8.23B
ROE 12.53% ROA 8.22%
Gross Margin 30.18% Operating Margin 11.17%
Net Margin 7.93% Free Cash Flow (TTM) 7.52B
ROIC 11.77% FCF Growth (3Y) 13.72%
Safety
Debt / Equity 0.11 Current Ratio 2.64
Interest Coverage 1449.13 Dividend Yield 0.02%
Valuation
P/E Ratio 0.12 P/B Ratio 0.01
P/S Ratio 0.01 PEG Ratio 2.79
EV/EBITDA -1.24 Dividend Yield 0.02%
Market Cap 997.73M Enterprise Value -14.39B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 103.75B 95.54B 91.42B 86.95B 81.61B
Net Income 8.23B 7.50B 8.11B 7.20B 5.99B
EPS (Diluted) 114.87 103.50 109.30 96.21 80.03
Gross Profit 31.32B 29.25B 28.45B 25.54B 25.93B
Operating Income 11.59B 10.44B 11.40B 9.34B 9.89B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 100.14B 95.83B 97.48B 96.11B 94.23B
Total Liabilities 33.43B 31.17B 33.51B 29.95B 31.46B
Shareholders' Equity 66.71B 64.66B 63.97B 66.15B 62.76B
Total Debt 7.19B 3.60B 6.19B 3.10B 4.70B
Cash & Equivalents 22.57B 13.19B 17.61B 18.72B 14.35B
Current Assets 69.96B 61.23B 62.66B 59.90B 58.72B
Current Liabilities 26.49B 26.10B 27.31B 25.72B 25.60B

Strategy Scores

This stock passed the criteria for 3 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Cash Flow Compounder
#466 of 1024
47
Custom Deep Value Investing (Seth Klarman)
#306 of 820
49
Value Defensive Investing (Benjamin Graham)
#516 of 708
16

Recent Activity

Entered Cash Flow Compounder
Mar 24, 2026
Entered Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entered Defensive Investing (Benjamin Graham)
Mar 24, 2026